Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells

Journal: Nature Immunology

Published: 2018-04-09

DOI: 10.1038/s41590-018-0082-6

Affiliations: 21

Authors: 25

Go to article
Institutions FC
Pathophysiology of Rheumatic Inflammation, DRFZ, Germany 0.20
Charité Medical Department - Division of Hematology, Oncology and Tumor Immunology, Germany 0.13
Institute of Virology, MHH, Germany 0.12
Research Group Therapeutic Gene Regulation, DRFZ, Germany 0.08
Department of Genetics and Epigenetics, Saar-Uni, Germany 0.08
Institute of Immunology, MHH, Germany 0.06
Marien Hospital Herne, RUB, Germany 0.05
Research Group Inflammation Biology, DRFZ, Germany 0.04
Systems Biology of Inflammation, DRFZ, Germany 0.04
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, MHH, Germany 0.02
Charité Institute of Virology, Germany 0.02
Labor Berlin - Charité Vivantes GmbH, Germany 0.02
IRCCS Azienda Ospedaliera Universitaria San Martino, Italy 0.02
Department of Experimental Medicine (DIMES), University of Genova, Italy 0.02
Research Group Cell Biology, DRFZ, Germany 0.02
Charité Medical Department I - Division of Gastroenterology, Infectiology and Rheumatology, Germany 0.02
Experimental and Clinical Research Center (ECRC), Germany 0.01
Berlin Institute of Health (BIH), Germany 0.01
Charité Institute for Medical Immunology, Germany 0.01
Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Germany 0.01